U S PHYSICAL THERAPY INC /NV Long-Term Debt
U S PHYSICAL THERAPY INC /NV (USPH) had Long-Term Debt of $215.46 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-07
- 2026-06-30: Long-term Debt, Excluding Current Maturities $215.46M.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $194.04M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $152.59M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $151.46M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-06-30 | $215.46M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $194.04M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $152.59M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $151.46M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $151.91M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $157.24M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $142.53M 10-K · filed 2026-02-27 |
| 2024-09-30 | $132.92M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $135.70M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $136.75M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $138.99M 10-K · filed 2025-03-03 |
| 2023-09-30 | $141.50M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $143.46M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $182.68M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $175.83M 10-K · filed 2024-02-29 |
| 2022-09-30 | $146.69M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $148.89M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $122.13M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $117.59M 10-K · filed 2023-02-28 |
| 2021-09-30 | $35.27M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $38.82M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $16.57M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $16.60M 10-K · filed 2022-03-01 |
| 2020-09-30 | $7.51M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $33.69M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $118.60M 10-Q · filed 2020-05-21 |
| 2019-12-31 | $50.36M 10-K · filed 2021-03-01 |
| 2019-09-30 | $55.29M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $66.32M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $29.52M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $38.40M 10-K · filed 2020-02-28 |
| 2018-09-30 | $54.66M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $56.61M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $42.78M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $56.73M 10-K · filed 2019-03-18 |
| 2017-09-30 | $59.95M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $73.35M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $62.80M 10-Q · filed 2017-06-29 |
| 2016-12-31 | $50.60M 10-K · filed 2018-03-14 |
| 2016-09-30 | $40.55M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $47.05M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $57.12M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $48.34M 10-K · filed 2017-06-07 |
| 2015-09-30 | $47.68M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $42.06M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $41.98M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $34.73M 10-K · filed 2016-03-04 |
| 2014-09-30 | $46.95M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $45.45M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $45.95M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $40.65M 10-K · filed 2015-03-12 |
| 2013-09-30 | $14.55M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $16.15M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $20.73M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $17.57M 10-K · filed 2014-03-11 |
| 2012-09-30 | $16.27M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $20.27M 10-Q/A · filed 2012-09-06 |
| 2011-12-31 | $23.78M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |